Press release
Global Anti-Vascular Endothelial Growth Factor Therapeutics Market Projected to Surpass $13.49 Billion by 2029 with 2% Annual Growth
What market dynamics are playing a key role in accelerating the growth of the anti-vascular endothelial growth factor therapeutics market?The rise in ophthalmic diseases is predicted to accelerate the expansion of the anti-vascular endothelial growth factor therapeutics market. The definition of the prevalence of ophthalmic diseases includes the count or percentage of people in a particular population who are diagnosed with or show certain eye conditions or illnesses. Anti-vascular endothelial growth factor therapeutics are instrumental in decreasing the prevalence of eye diseases by effectively tackling conditions such as wet age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion. In October 2022, the World Health Organization estimates that roughly 2.2 billion people globally have issues with near or distance vision, and 1 billion have near or distance vision impairment. Additionally, out of these, 88.4 million suffer from refractive error, 94 million are dealing with cataracts, 8 million have age-related macular degeneration, and about 3.9 million are affected by diabetic retinopathy. Consequently, the spurge in ophthalmic diseases is propelling the growth of the anti-vascular endothelial growth factor therapeutics market.
Get Your Anti-Vascular Endothelial Growth Factor Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/report/anti-vascular-endothelial-growth-factor-therapeutics-global-market-report
How will the growth rate of the anti-vascular endothelial growth factor therapeutics market shape industry trends by 2034?
The market size of anti-vascular endothelial growth factor therapeutics has seen slight growth in recent years. It is expected to expand from a value of $12.2 billion in 2024 to $12.31 billion in 2025, with a compound annual growth rate (CAGR) of 1.0%. The growth seen in the past years can be traced back to an increase in age-related macular degeneration, a rise in diabetic retinopathy occurrences, advancements in the diagnosis of retinal diseases, clinical success and effectiveness, along with a transition towards outpatient care.
The market for anti-vascular endothelial growth factor therapies is predicted to witness steady expansion in the coming years, growing to an estimated $13.49 billion by 2029 with a compound annual growth rate (CAGR) of 2.3%. This growth across the predicted period can be ascribed to factors such as an aging demographic, rising cases of eye diseases, increasing use in retinal disorder treatment, the advent of next-gen therapies, greater focus on early-stage intervention, and global initiatives to improve health and treatment accessibility. Key trends set to shape the forecast period include a rise in application for cancer treatment, an emphasis on combination treatments in eye care, the development of biosimilar products, studies on resistant mechanisms, and the incorporation of imaging technologies.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10683&type=smp
What trends are poised to drive the future success of the anti-vascular endothelial growth factor therapeutics market?
The development of innovative treatments is a noteworthy trend emerging in the anti-vascular endothelial growth factor therapeutics industry. Firms functioning in this market are embracing innovative therapeutics in order to maintain their market standing. For example, in May 2022, Ashvattha Therapeutics Inc., a clinical-stage biopharmaceutical company based in the US, announced Phase 1 safety data for healthy participants regarding subcutaneous anti-VEGF wet AMD (age-related macular degeneration) and DME (diabetic macular edema) candidates. D-4517.2 is a first-of-its-kind treatment designed to satisfy the unfulfilled needs of those with DME conditions. This D-4517.2 therapy is designed for self-administration through an autoinjector. The D-4517.2 autoinjector allows patients to personally administer their medication on a monthly basis at home.
Which primary segments of the anti-vascular endothelial growth factor therapeutics market are driving growth and industry transformations?
The anti-vascular endothelial growth factor therapeutics market covered in this report is segmented -
1) By Product: Eylea, Lucentis, Beovu
2) By Disease: Macular Edema, Diabetic Retinopathy, Retinal Vein Occlusion, Age-related Macular Degeneration
3) By End Users: Hospitals, Clinics, Oncology Centers, Other End Users
Subsegments:
1) By Eylea: Indications, Dosage Forms
2) By Lucentis: Indications, Dosage Forms
3) By Beovu: Indications, Dosage Forms
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10683
Which geographical regions are pioneering growth in the anti-vascular endothelial growth factor therapeutics market?
North America was the largest region in the anti-vascular endothelial growth factor therapeutics market in 2024.Europe is expected to be the fastest-growing region in the global anti-vascular endothelial growth factor therapeutics market report during the forecast period. The regions covered in the anti-vascular endothelial growth factor therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Who are the influential players reshaping the anti-vascular endothelial growth factor therapeutics market landscape?
Major companies operating in the anti-vascular endothelial growth factor therapeutics market include F. Hoffmann-La Roche AG, Biogen Inc., Pfizer Inc., Coherus BioSciences Inc., Eli Lilly and Company, Bausch Health Companies Inc., Viatris Inc., Xbrane Biopharma AB, Bayer AG, Regeneron Pharmaceuticals Inc., Genentech Inc, Allergan Inc., Novartis AG, kyowa Kirin Co. Ltd., Amgen Inc., AstraZeneca plc, Merck & Co. Inc., Johnson & Johnson Private Limited, Sanofi S.A., AbbVie Inc., Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Daiichi Sankyo Company Limited, Eisai Co. Ltd., Gilead Sciences Inc., Vertex Pharmaceuticals Incorporated, Alexion Pharmaceuticals Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10683&type=smp
What Is Covered In The Anti-Vascular Endothelial Growth Factor Therapeutics Global Market Report?
• Market Size Forecast: Examine the anti-vascular endothelial growth factor therapeutics market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the anti-vascular endothelial growth factor therapeutics market for a structured understanding.
• Key Players Overview: Analyze major players in the anti-vascular endothelial growth factor therapeutics market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the anti-vascular endothelial growth factor therapeutics market.
• Segment Contributions: Evaluate how different segments drive overall growth in the anti-vascular endothelial growth factor therapeutics market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the anti-vascular endothelial growth factor therapeutics market.
• Industry Challenges: Identify potential risks and obstacles affecting the anti-vascular endothelial growth factor therapeutics market.
• Competitive Landscape: Review strategic developments in the anti-vascular endothelial growth factor therapeutics market, including expansions, agreements, and new product launches.
Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.
Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Anti-Vascular Endothelial Growth Factor Therapeutics Market Projected to Surpass $13.49 Billion by 2029 with 2% Annual Growth here
News-ID: 3943515 • Views: …
More Releases from The Business Research Company

Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…

Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…

Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…

Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Factor
Aliphatic Polyether Market Demand, Growth Factor, Research Factor, Analysis and …
The Aliphatic Polyether market has gained momentum in recent years due to its broad applications across industries such as automotive, construction, healthcare, and electronics. Known for its excellent flexibility, chemical resistance, and low-temperature performance, aliphatic polyether has become a preferred choice in manufacturing high-performance materials like adhesives, sealants, coatings, and elastomers.
The Aliphatic Polyether market was valued at USD 18.44 billion in 2023. It is projected to grow from USD…
Lactic Acid Ethyl Ester Market Demand, Growth Factor, Research Factor, Analysis …
The lactic acid ethyl ester market is gaining momentum as the demand for environmentally friendly, biodegradable, and sustainable chemicals continues to rise. Lactic acid ethyl ester, also known as ethyl lactate, is a naturally derived solvent obtained from renewable resources such as corn, sugar beets, and other plant materials. It is widely used across various industries, including pharmaceuticals, food and beverages, personal care, paints and coatings, and industrial cleaning due…
Trending News: Multi-Factor Authentication (MFA) Market Growth Factor Analysis t …
(United States, OR Poland) Multi-Factor Authentication (MFA) Market : According to a new report added by Reports Big Market Report, titled, “Multi-Factor Authentication (MFA) Market: Global Opportunity Analysis and Industry Forecast, 2021 – 2026”
The Multi-Factor Authentication (MFA) Market research by Market Study Report. It offers a feasibility analysis for investment and returns supported with data on development trend analysis across important regions of the world.
This…
Two-Factor Biometrics Market Size, Growth Strategies, Competitive Landscape, Fac …
The latest market research report published by Reports and Data, titled ‘Global Two-Factor Biometrics Market,’ is an in-depth study of the Two-Factor Biometrics industry and its key segments. The authors of the report have performed quantitative and qualitative analyses of the industry, focusing on the most imperative factors that influence its growth during the forecast period. Some of those factors include key market dynamics, pricing structure, product portfolios, end-use industries,…
Authentication Software Market Trends, Business Growth, Key Players, Application …
Global Authentication Software Market report provides a detailed market overview of the industry including definitions, classifications, applications, challenges, competitive scenario and industry chain structure. The report also analysis the Authentication Software Market verticals and horizontals, Market Size and CAGR comparison by region.
The study objectives are to provide the Authentication Software market trends, future opportunities, SWOT analysis, development, key drivers, top players and their analysis etc. Major regions covered in this…
Global Coagulation Factor IX Market Projections Highlighting Primary Trends unti …
Coagulation factor IX isn’t made by the body of hemophilia B patient thereby, external injection of coagulation factor IX is necessary for the treatment of such disorder. Coagulation factor IX is always injected directly into a vein. Lack of treatment options for hemophilia B disorder have further increased adoption of coagulation factor IX. This has brought number of opportunities for new entrants to enter in Coagulation Factor IX Market.
Request Brochure…